Join us via Zoom on Wednesday, May 14th at 6pm ET / 3pm PT for the first Clinical Update webinar in our 2025 series.

A comprehensive approach to your management plan is so important for treating narcolepsy. This includes good sleep habits, lifestyle changes, and developing support systems. Dr. Jeremy McConnell, a board-certified physician in sleep medicine, will discuss strategies for developing a management plan and provide details on a sodium oxybate extended-release treatment option for Excessive Daytime Sleepiness (EDS) and cataplexy.

There will be a live Q&A so please bring your questions!

Presented by and Q&A with:

Jeremy David McConnell, MD is a board-certified physician in family medicine, obesity medicine, and sleep medicine. He currently holds positions at Morpheus Clinical Research, Physicians-NOW, and his own medical practice. A graduate from Albany Medical College, he completed his residency at Bayfront Family Practice. He holds memberships in the American Board of Family Medicine and Obesity Medicine Association, where he earned his fellowship. His dedication to healthcare has earned him titles including Obesity Medicine Association’s Clinician of the Year in 2019 and Inspire Physician of Excellence in 2022.

Q&A with:

Jennifer Gudeman, PharmD is Senior Vice President of Medical and Clinical Affairs at Avadel Pharmaceuticals. Jennifer has more than 20 years’ experience in the pharmaceutical industry. She has led or contributed to seven commercial product launches and four clinical development programs. Jennifer has relationships with medical societies and patient advocacy organizations. This helps ensure that medications fulfill their clinically proven therapeutic benefits to patients and clinicians. Jennifer has published numerous peer-reviewed papers over her career. She is currently most proud of the plain language summaries published in narcolepsy.

Thank you to Avadel Pharmaceuticals for sponsoring this webinar: